Riskpilot← Back to searchSign inGet full accessLymedic AB
ABActiveOrg 5569440729Dagvattengatan 8 C Lgh 1601Hospital activities · NACE 8610Est. 20130 employees
Revenue 2024
SEK 120K
+6% vs 2023
EBITDA margin
65.5%
-10% vs 2023
Equity ratio
79.9%
Financial strength
Net profit 2024
SEK 59K
-27% vs 2023
| Revenue | SEK 120K | +6% |
| EBITDA | SEK 78K | -10% |
| Net profit | SEK 59K | -27% |
| Total assets | SEK 275K | +35% |
| Equity | SEK 220K | +37% |
| Employees | 0 | — |
Legal name
Lymedic AB
Org number
5569440729
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
1 oktober 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall erbjuda läkartjänst och utveckla programvara och därmed förenlig verksamhet.
Address
Dagvattengatan 8 C Lgh 1601
Email
john.ly@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 40 | 82 | 0 | 0 | 11 | 113 | 120 |
| Staff expenses | — | — | — | — | — | — | — | — | −1 | −1 |
| EBITDA | 481 | 78 | −31 | 15 | 66 | −9 | −19 | −20 | 87 | 78 |
| Depreciation & amort. | −0 | −0 | −2 | −2 | −2 | −2 | −2 | — | — | −4 |
| EBIT | 481 | 78 | −33 | 13 | 64 | −11 | −21 | −20 | 87 | 75 |
| Net financials | −375 | 21 | −251 | −204 | — | — | — | — | 1 | −0 |
| Profit before tax | 105 | 235 | −284 | −90 | 64 | −11 | −21 | −20 | 88 | 75 |
| Tax | −101 | −47 | −0 | −0 | −11 | −0 | −0 | — | −7 | −15 |
| Net profit | 4 | 188 | −284 | −90 | 53 | −11 | −21 | −20 | 81 | 59 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 768 | 1 887 | 1 002 | 113 | 155 | 145 | 112 | 92 | 204 | 275 |
| Equity | 464 | 653 | 169 | 79 | 132 | 121 | 100 | 80 | 161 | 220 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 168 | 1 234 | 833 | 34 | 23 | 24 | 12 | 12 | 43 | 55 |
| Total debt | 168 | 1 234 | 833 | 34 | 23 | 24 | 12 | 12 | 43 | 55 |
EBITDA margin
65.5%
This company
15.8%
Market median
+315% vs market
20152024
Equity ratio
79.9%
This company
38.2%
Market median
+109% vs market
20152024
Return on equity
27.0%
This company
18.4%
Market median
+47% vs market
20152024
Net profit margin
49.6%
This company
8.1%
Market median
+512% vs market
20152024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20152024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JD Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2024 | — | — | |
JL | Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lymedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Do | Chief Auditor | 0 companies |
| Anne Viktoria Alexiz Knöös | Deputy Board Member | 0 companies |
| Mona Diana Petra Knöös | Deputy Board Member | 0 companies |
| John Ly | Board of Directors | 0 companies |